Biogen Announces Board Changes
Biogen announced the appointment of Susan Langer as a new member of its board of directors. Susan currently serves as the President of Souffle Therapeutics, a privately held biotech firm. Previously, she held executive roles at Kojin Therapeutics and Paratus Sciences.
Biogen is a biotechnology company focused on developing therapies for neurological and neurodegenerative diseases.